Old Web
English
Sign In
Acemap
>
authorDetail
>
Jabed Seraj
Jabed Seraj
Princeton University
Trifluridine
Pharmacology
Thymidine phosphorylase
Colorectal cancer
Medicine
4
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An open-label, randomized, parallel-group study of the pharmacokinetics of trifluridine as a component of TAS-102 versus FTD alone.
2016
Journal of Clinical Oncology
Weijing Sun
Lee S. Rosen
Drew W. Rasco
Kenichiro Yoshida
Jabed Seraj
Geoffrey I. Shapiro
James M. Cleary
Show All
Source
Cite
Save
Citations (5)
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors
2016
Cancer Chemotherapy and Pharmacology
Johanna C. Bendell
Manish R. Patel
Kenichiro Yoshida
Jabed Seraj
Racquel Weaver
Charlotte Lemech
Thomas G. Todaro
Shubham Pant
Hendrik-Tobias Arkenau
Show All
Source
Cite
Save
Citations (12)
Human mass balance study of TAS-102 using (14)C analyzed by accelerator mass spectrometry.
2016
Cancer Chemotherapy and Pharmacology
James J. Lee
Jabed Seraj
Kenichiro Yoshida
Hirokazu Mizuguchi
Sandra Strychor
Jillian Fiejdasz
Tyeler Faulkner
Robert A. Parise
Patrick Fawcett
Laura Pollice
Scott Mason
Jeremy Hague
Marie Croft
James Nugteren
Charles Tedder
Weijing Sun
Edward Chu
Jan H. Beumer
Show All
Source
Cite
Save
Citations (17)
Mass balance study of TAS-102 using 14C labeling analyzed by accelerator mass spectrometry.
2015
Journal of Clinical Oncology
James J. Lee
Jabed Seraj
Kenichiro Yoshida
Milind Narurkar
Hirokazu Mizuguchi
Sandra Strychor
Jillian Fiejdasz
Tyeler Faulkner
Laura Pollice
Scott Mason
Weijing Sun
Edward Chu
Marie Croft
James Nguteren
Charles Tedder
Jan H. Beumer
Show All
Source
Cite
Save
Citations (0)
1